secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardant Health, Inc. (GH)
CIK:        0001576280
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001193125-24-075436
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardant Health co-CEOs receive new annual and long-term equity grants; base salary remains $1
--------------------------------------------------------------------------------

- Each co-CEO gets annual RSU and PSU awards with $800,000 target value each, in lieu of salary and bonus.
- 2024 long-term awards: $5M RSU and $5M PSU per co-CEO, vesting over three years with performance metrics.
- Founders PSU award from May 2020 cancelled as part of new agreement.
- Base salary stays at $1; severance plan Tier 1 continues but cash severance based on $1 salary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576280/000119312524075436/0001193125-24-075436-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576280/000119312524075436/d56043d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-075436

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer